Modulating gene function with peptide nucleic acids (PNA)

Antisense Drug Technology: Principles, Strategies, and Applications, Second Edition

Volumn , Issue , 2007, Pages 507-518

  Nielsen, Peter E ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77958180798     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (87)

1. Nielsen PE, Egholm M, Berg RH, and Buchardt O: Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science, 254: 1497; 1991.
2. Marin VL, Roy S, and Armitage BA: Recent advances in the development of peptide nucleic acid as a gene-targeted drug. Expert Opinion on Biological Therapy, 4: 337; 2004.
3. Geller BL: Antibacterial antisense. Current Opinion in Molecular Therapeutics, 7: 109 2005.
4. Kaihatsu K, Janowski BA, and Corey DR: Recognition of chromosomal DNA by PNAs. Chemistry and Biology, 11: 749 2004.
5. Lundin KE, Good L, Stromberg R et al.: Biological activity and biotechnological aspects of peptide nucleic acid. Advances in Genetics, 56: 1 2006.
6. Nielsen PE: Peptide nucleic acid. A molecule with two identities. Accounts of Chemical Research, 32:624; 1999.
7. Kumar VA and Ganesh KN: Conformationally constrained PNA analogues: structural evolution toward DNA/RNA binding selectivity. Accounts of Chemical Research, 38: 404 2005.
8. Püschl A, Sforza S, Haaima G et al.: Peptide nucleic acids (PNAs) with a functional backbone. Tetrahedron Letters, 39: 4707 1998.
9. Kosynkina L, Wang W, and Liang TC: A convenient synthesis of chiral peptide nucleic acid (PNA) monomers. Tetrahedron Lett, 35: 5173 1994.
10. Doyle DF, Braasch DA, Simmons CG et al.: Inhibition of gene expression inside cells by peptide nucleic acids: effect of mRNA target sequence, mismatched bases, and PNA length. Biochemistry, 40:53; 2001.
11. Liu Y, Braasch DA, Nulf CJ et al.: Efficient and isoform-selective inhibition of cellular gene expression by peptide nucleic acids. Biochemistry, 43: 1921 2004.
12. Shiraishi T and Nielsen PE: Down-regulation of MDM2 and activation of p53 in human cancer cells by antisense 9-aminoacridine-PNA (peptide nucleic acid) conjugates. Nucleic Acids Research, 32:4893; 2004.
13. Kilk K, Elmquist A, Saar K, et al.: Targeting of antisense PNA oligomers to human galanin receptor type 1 mRNA. Neuropeptides, 38: 316 2004.
14. Sazani P, Kang SH, Maier MA, et al.: Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs. Nucleic Acids Research, 29: 3965 2001.
15. Cartegni L and Krainer AR: Correction of disease-associated exon skipping by synthetic exon-specific activators. Nature Structural Biology, 10: 120 2003.
16. Siwkowski AM, Malik L, Esau CC, et al.: Identification and functional validation of PNAs that inhibit murine CD40 expression by redirection of splicing. Nucleic Acids Research, 32: 2695 2004.
17. Wilusz JE, Devanney SC, and Caputi M: Chimeric peptide nucleic acid compounds modulate splicing of the bcl-x gene in vitro and in vivo. Nucleic Acids Research, 33: 6547 2005.
18. Herbert BS, Pitts AE, Baker SI et al.: Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proceedings of the National Academy of Science USA, 96: 14,276; 1999.
19. Folini M, Berg K, Millo E et al.: Photochemical internalization of a peptide nucleic acid targeting the catalytic subunit of human telomerase. Cancer Research, 63: 3490 2003.
20. Nielsen PE, Egholm M, and Buchardt O: Evidence for (PNA)2/DNA triplex structure upon binding of PNA to dsDNA by strand displacement. Journal of Molecular Recognition, 7: 165 1994.
21. Bentin T, Hansen GI, and Nielsen PE: Structural diversity of target specific homopyrimidine peptide nucleic acid-dsDNA complexes. Nucleic Acids Research, 34: 5790 2006.
22. Bentin T and Nielsen PE: Superior duplex DNA strand invasion by acridine conjugated peptide nucleic acids. Journal of the American Chemical Society, 125: 6378 2003.
23. Egholm M, Christensen L, Dueholm KL et al.: Efficient pH-independent sequence-specific DNA binding by pseudoisocytosine-containing bis-PNA. Nucleic Acids Research, 23: 217 1995.
24. Nielsen PE and Christensen L: Strand displacement binding of a duplex-forming homopurine PNA to a homopyrimidine duplex DNA target. Journal of the American Chemical Society, 118: 2287 1996.
25. Zhang X, Ishihara T, and Corey DR: Strand invasion by mixed base PNAs and a PNA-peptide chimera. Nucleic Acids Research, 28: 3332 2000.
26. Lohse J, Dahl O, and Nielsen PE: Double duplex invasion by peptide nucleic acid: a general principle for sequence-specific targeting of double-stranded DNA. Proceedings of the National Academy of Science USA, 96: 11,804; 1999.
27. Peffer NJ, Hanvey JC, Bisi JE et al.: Strand-invasion of duplex DNA by peptide nucleic acid oligomers. Proceedings of the National Academy of Science USA, 90: 10,648; 1993.
28. Nielsen PE, Egholm M, and Buchardt O: Sequence-specific transcription arrest by peptide nucleic acid bound to the DNA template strand. Gene, 149: 139 1994.
29. Janowski BA, Kaihatsu K, Huffman KE et al.: Inhibiting transcription of chromosomal DNA with antigene peptide nucleic acids. Nature Chemical Biology, 1: 210 2005.
30. Hwang JT, Baltasar FE, Cole DL et al.: Transcription inhibition using modified pentanucleotides. Bioorganic and Medicinal Chemistry, 11: 2321 2003.
31. Milne L, Xu Y, Perrin DM, and Sigman DS: An approach to gene-specific transcription inhibition using oligonucleotides complementary to the template strand of the open complex. Proceedings of the National Academy of Science USA, 97: 3136 2000.
32. Møllegaard NE, Buchardt O, Egholm M, and Nielsen PE: Peptide nucleic acid-DNA strand displacement loops as artificial transcription promoters. Proceedings of the National Academy of Science USA, 91: 3892 1994.
33. Wang G, Xu X, Pace B, Dean DA et al.: Peptide nucleic acid (PNA) binding-mediated induction of human γ-globin gene expression. Nucleic Acids Research, 27: 2806 1999.
34. Kim KH, Nielsen PE, and Glazer PM: Site-specific gene modification by PNAs conjugated to psoralen. Biochemistry, 45: 314 2006.
35. Zhilina ZV, Ziemba AJ, Nielsen PE, and Ebbinghaus SW: PNA-nitrogen mustard conjugates are effective suppressors of HER-2/neu and biological tools for recognition of PNA/DNA Interactions. Bioconjugate Chemistry, 17: 214 2006.
36. Ziemba AJ, Zhilina ZV, Krotova-Khan Y et al.: Targeting and regulation of the HER-2/neu oncogene promoter with bis-peptide nucleic acids. Oligonucleotides, 15: 36 2005.
37. Urnov FD, Miller JC, Lee YL et al. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature, 435: 646 2005.
38. Cutrona G, Carpaneto EM, Ulivi M et al.: Effects in live cells of a c-myc anti-gene PNA linked to a nuclear localization signal. Nature Biotechnology, 18: 300 2000.
39. Pession A, Tonelli R, Fronza R et al.: Targeted inhibition of NMYC by peptide nucleic acid in N-myc amplified human neuroblastoma cells: cell-cycle inhibition with induction of neuronal cell differentiation and apoptosis. International Journal of Oncology, 24: 265 2004.
40. Cogoi S, Codognotto A, Rapozzi V et al.: Transcription inhibition of oncogenic KRAS by a mutationselective peptide nucleic acid conjugated to the PKKKRKV nuclear localization signal peptide. Biochemistry, 44: 10,510; 2005.
41. Tonelli R, Purgato S, Camerin C et al.: Anti-gene peptide nucleic acid specifically inhibits MYCN expression in human neuroblastoma cells leading to cell growth inhibition and apoptosis. Molecular Cancer Therapy, 4: 779 2005.
42. Bendifallah N, Rasmussen FW, Zachar V et al.: Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of Antisense peptide nucleic acid (PNA). Bioconjugate Chemistry, 17: 750 2006.
43. Good L and Nielsen PE: Inhibition of translation and bacterial growth by peptide nucleic acid targeted to ribosomal RNA. Proceedings of the National Academy of Science USA, 95: 2073 1998.
44. Good L, Awasthi SK, Dryselius R et al.: Bactericidal antisense effects of peptide-PNA conjugates. Nature Biotechnology, 19: 360 2001.
45. Tan XX, Actor JK, and Chen Y: Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection. Antimicrobial Agents and Chemotherapy, 49: 3203 2005.
46. Frandsen N, Kjærulf S, Nielsen PE et al. (in preparation).
47. Jenssen H, Hamill P, and Hancock RE. Peptide antimicrobial agents. Clinical Microbiology Reviews, 19: 491 2006.
48. Dryselius R, Aswasti SK, Rajarao GK et al.: The translation start codon region is sensitive to antisense PNA inhibition in Escherichia coli. Oligonucleotides, 13: 427 2003.
49. Kulyte A, Dryselius R, Karlsson J and Good L: Gene selective suppression of nonsense termination using antisense agents. Biochimica et Biophysica Acta, 1730: 165 2005.
50. Dryselius R, Nekhotiaeva N, and Good L: Antimicrobial synergy between mRNA-and protein-level inhibitors. Journal of Antimicrobial Chemotherapy, 56: 97 2005.
51. Nekhotiaeva N, Awasthi SK, Nielsen PE, and Good L: Inhibition of Staphylococcus aureus gene expression and growth using antisense peptide nucleic acids. Molecular Therapy, 10: 652 2004.
52. Stock RP, Olvera A, Sánchez R et al.: Inhibition of gene expression in Entamoeba histolytica with antisense peptide nucleic acid oligomers. Nature Biotechnology, 19: 231 2001.
53. Sánchez R, Saralegui A, Olivos-Garcia A et al.: Entamoeba histolytica: intracellular distribution of the sec61alpha subunit of the secretory pathway and down-regulation by antisense peptide nucleic acids. Experimental Parasitology, 109: 241 2005.
54. Koppelhus U, Zachar V, Nielsen PE et al.: Efficient in vitro inhibition of HIV-1 gag reverse transcription by peptide nucleic acid (PNA) at minimal ratios of PNA/RNA. Nucleic Acids Research, 25: 2167 1997.
55. Kaushik N, Basu A, and Pandey VN: Inhibition of HIV-1 replication by anti-trans-activation responsive polyamide nucleotide analog. Antiviral Research, 56: 13 2002.
56. Riguet E, Tripathi S, Chaubey B et al.: A peptide nucleic acid-neamine conjugate that targets and cleaves HIV-1 TAR RNA inhibits viral replication. Journal of Medicinal Chemistry, 47: 4806 2004.
57. Chaubey B, Tripathi S, Ganguly S et al.: A PNA-transportan conjugate targeted to the TAR region of the HIV-1 genome exhibits both antiviral and virucidal properties. Virology, 331: 418 2005.
58. Pesce CD, Bolacchi F, Bongiovanni B et al.: Anti-gene peptide nucleic acid targeted to proviral HIV-1 DNA inhibits in vitro HIV-1 replication. Antiviral Research, 66: 13 2005.
59. Tripathi S, Chaubey B, Ganguly S et al.: Anti-HIV-1 activity of anti-TAR polyamide nucleic acid conjugated with various membrane transducing peptides. Nucleic Acids Research, 33: 4345 2005.
60. Turner JJ, Ivanova GD, Verbeure B et al.: Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells. Nucleic Acids Research, 33:6837; 2005.
61. Nulf CJ and Corey D: Intracellular inhibition of hepatitis C virus (HCV) internal ribosomal entry site (IRES)-dependent translation by peptide nucleic acids (PNAs) and locked nucleic acids (LNAs). Nucleic Acids Research, 32: 3792 2004.
62. Robaczewska M, Narayan R, Seigneres B et al.: Sequence-specific inhibition of duck hepatitis B virus reverse transcription by peptide nucleic acids (PNA). Journal of Hepatology, 42: 180 2005.
63. Hamilton SE, Simmons CG, Kathiriya IS, and Corey DR: Cellular delivery of peptide nucleic acids and inhibition of human telomerase. Chemistry & Biology, 6: 343 1999.
64. Ljungstrøm T, Knudsen H and Nielsen PE: Cellular Uptake of adamantyl conjugated peptide nucleic acids. Bioconjugate Chemistry, 10: 965 1999.
65. Shiraishi T, Nadia Bendifallah N, and Nielsen PE: Cellular delivery of polyheteroaromate-peptide nucleic acid (PNA) conjugates mediated by cationic lipids. Bioconjugate Chemistry, 17: 189 2006.
66. Fotin-Mleczek M, Fischer R, and Brock R: Endocytosis and cationic cell-penetrating peptides-a merger of concepts and methods. Current Pharmaceutical Design, 11: 3613 2005.
67. Koppelhus U, Awasthi SK, Zachar V et al.: Cell-dependent differential cellular uptake of PNA, peptides, and PNA-peptide conjugates. Antisense and Nucleic Acid Drug Development, 12: 51 2002.
68. Richard JP, Melikov K, Vives E et al. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. Journal of Biological Chemistry, 278: 585 2003.
69. Abes S, Williams D, Prevot P et al.: Endosome trapping limits the efficiency of splicing correction by PNA-oligolysine conjugates. Journal of Controlled Release, 110: 595 2006.
70. Wadia JS, Stan RV, and Dowdy SF: Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nature Medicine, 10: 310 2004.
71. Shiraishi T, Pankratova S, and Nielsen PE: Calcium ions effectively enhance the effect of antisense peptide nucleic acids conjugated to cationic tat and oligoarginine peptides. Chemistry & Biology, 12:923; 2005.
72. Shiraishi T and Nielsen PE: Photochemically enhanced cellular delivery of cell penetrating peptide-PNA conjugates. FEBS Letters, 580: 1451 2006.
73. Bøe S, Hovig E: Photochemically induced gene silencing using PNA-peptide conjugates. Oligonucleotides, 16: 145 2006.
74. Albertshofer K, Siwkowski AM, Wancewicz EV et al.: Structure-activity relationship study on a simple cationic peptide motif for cellular delivery of antisense peptide nucleic acid. Journal of Medicinal Chemistry, 48: 6741 2005.
75. Maier MA, Esau CC, Siwkowski AM et al.: Evaluation of basic amphipathic peptides for cellular delivery of antisense peptide nucleic acids. Journal of Medicinal Chemistry, 49: 2534 2006.
76. Nelson MH, Stein DA, Kroeker AD et al.: Arginine-rich peptide conjugation to morpholino oligomers:effects on antisense activity and specificity. Bioconjugate Chemistry, 16: 959 2005.
77. El-Andaloussi S, Johansson H, Lundberg P and Langel Ü: Induction of splice correction by cellpenetrating peptide nucleic acids. The Journal of Gene Medicine, 2006 (in press).
78. Filipovska A, Eccles MR, Smith RAJ, and Murphy MP: Delivery of antisense peptide nucleic acids (PNAs) to the cytosol by disulphide conjugation to a lipophilic cation. FEBS Letters, 556: 180 2004.
79. 2′ ions. Journal of the American Chemical Society, 128: 5986 2006.
80. Dragulescu-Andrasi A, Zhou P, He G, and Ly DH: Cell-permeable GPNA with appropriate backbone stereochemistry and spacing binds sequence-specifically to RNA. Chemical Communications, 244; 2005.
81. Hamzavi R, Dolle F, Tavitian B et al.: Modulation of the pharmacokinetic properties of PNA:Preparation of galactosyl, mannosyl, fucosyl, N-acetylgalactosaminyl, and N-acetylglucosaminyl derivatives of aminoethylglycine peptide nucleic acid monomers and their incorporation into PNA oligomers. Bioconjugate Chemistry, 14: 941 2003.
82. McMahon BM, Stewart JA, Jackson J et al.: Intraperitoneal injection of antisense peptide nucleic acids targeted to the mu receptor decreases response to morphine and receptor protein levels in rat brain. Brain Research, 904: 345 2001.
83. McMahon BM, Stewart JA, Bitner MD et al.: Peptide nucleic acids specifically cause antigene effects in vivo by systemic injection. Life Sciences, 71: 325 2002.
84. Boules M, Williams K, Gollatz E et al.: Down-regulation of amyloid precursor protein by peptide nucleic acid in vivo. Journal of Molecular Neuroscience, 24: 123 2004.
85. Kristensen E: In vitro and in vivo studies on pharmacokinetics and metabolism of PNA constructs in rodents. In Peptide Nucleic Acids: Methods and Protocols, PE Nielsen ed. Copenhagen: Humana Press (Totowa, NJ, United States); 2002, pp. 259-269.
86. McMahon BM, Mays D, Lipsky J et al.: Pharmacokinetics and tissue distribution of a peptide nucleic acid after intravenous administration. Antisense and Nucleic Acid Drug Development, 12: 65 2002.
87. Sazani P, Gemignani F, Kang S-H et al.: Systemically delivered antisense oligomers upregulate gene expression in mouse tissues. Nature Biotechnology, 20: 1228 2002.